Aging-dependent reduction of KAT7 (HBO1) activity impairs imMKCL-based platelet production by promoting immune properties
The master cell bank (MCB) system is essential for regenerative cell therapy. We have developed iPSC-based immortalized megakaryocyte progenitor cell lines (imMKCLs) as an MCB for iPSC-platelet (iPSC-PLT) transfusion. However, imMKCLs exhibit both thrombopoietic and immune-skewed properties, with enhanced immune activity impairing platelet producibility. The link between immune properties and thrombopoietic efficiency remains unclear. Here, we demonstrate that G1 and G2/M interphases in proliferating imMKCLs contribute to platelet generation, while lysine acetyltransferase 7 (KAT7) suppresses immune-biased dominancy to maintain these interphases. KAT7 inhibition with WM3835 increases G0 cells, mimicking imMKCL aging, and induces cGAS-STING activation, chromatin instability, TNF-a, IFN-ß and pro-inflammatory cytokine secretion. Additionally, TNF-a treatment recapitulates the transition to G0 seen with KAT7 loss. These findings identify KAT7 as a key regulator of imMKCL proliferation by preventing immune-skewed properties, highlighting its potential as a quality control marker in iPSC-PLT manufacturing. Overall design: RNA-seq profiling of imMKCLs at proliferation phase (present of doxcycline) with or without KAT7 inhibitor (WM3835)